AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Glaukos Reports Q2 Earnings, Revenue Tops Consensus
ByAinvest
Wednesday, Jul 30, 2025 9:16 pm ET1min read
Glaukos reported Q2 EPS of 24 cents, in line with consensus of 26 cents. Revenue reached $124.1M, surpassing the consensus of $115.5M. CEO Thomas Burns attributed the record results to successful execution of strategic plans and advancing pipeline of novel technologies for chronic eye diseases.
Glaukos Corp (GKOS) reported its Q2 2025 earnings on July 30, 2025, with an earnings per share (EPS) of -$0.24, slightly better than the forecast of -$0.26, marking a 7.69% surprise. Revenue reached $124.1 million, exceeding the expected $115.52 million by 7.35% [1].Despite these positive results, the stock experienced a minor drop of 0.28% in aftermarket trading, closing at $93.5. With a market capitalization of $5.42 billion, InvestingPro analysis suggests the stock is currently trading above its Fair Value. The company's U.S. Glaucoma franchise led the growth, with sales surging by 45% year-over-year. International sales also showed strong performance, increasing by 20%.
CEO Thomas Burns attributed the record results to successful execution of strategic plans and advancing pipeline of novel technologies for chronic eye diseases. The company's full-year 2025 net sales guidance was raised to $480-$486 million, reflecting confidence in continued growth [1].
Key Takeaways:
- Glaukos Corp’s Q2 EPS outperformed expectations by 7.69%.
- Revenue grew 30% year-over-year, reaching $124.1 million.
- Stock price decreased by 0.28% in aftermarket trading.
- Full-year 2025 sales guidance was raised to $480-$486 million.
- Significant growth in U.S. Glaucoma franchise sales.
The company maintains impressive financial health metrics, including a strong current ratio of 6.49 and a moderate debt level, with total debt representing just 2% of total capital. According to InvestingPro data, the company has achieved a 10% revenue CAGR over the past five years [1].
References:
[1] https://www.investing.com/news/transcripts/earnings-call-transcript-glaukos-corp-beats-q2-2025-earnings-estimates-stock-dips-93CH-4161505
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet